Ensuring multiple sclerosis (MS) patients’ adherence to therapy is often challenging, but it is crucial to their survival and health-related quality of life (HRQoL). The aim of the present study was to outline connections between adherence, physical and mental HRQoL, levels of psychological readiness to engage in a treatment, levels of social support, anthropometric, socio-demographic and clinical factors in patients suffering from MS. This cross-sectional study involved a sample of 237 Italian MS patients. A survey was conducted with a structured self-administered online questionnaire using validated measures of quality of life, adherence to therapy and anthropometric, socio-demographic, psychological and clinical variables. A path analysi...
Objective: People with multiple sclerosis often suffer from distress, reduced societal participation...
AbstractMultiple sclerosis (MS) is an unpredictable, inflammatory, chronic, potentially disabling, n...
Objective Multiple Sclerosis (MS) as a progressive disease has remarkable consequences on the patien...
Objective: This cross-sectional study aims to evaluate the impact of the disability status, psycholo...
WOS: 000444552800005PubMed ID: 30138155Background: Adherence to medication treatment in patients wit...
BACKGROUND: Health-related quality of life (QOL) is a key outcome for people with multiple sclerosis...
Purpose. Quality of life (QoL) is an important measure of the burden of disease and could be useful ...
Objective: The aim of this study was to obtain information concerning the relationship between the s...
Optimizing quality of life (QOL) and self-management in people with multiple sclerosis (MS) is incre...
Multiple sclerosis (MS) is one of the most disabling chronic neurological diseases. Individual perce...
Background and Objectives Multiple sclerosis (MS) has a broad spectrum of physical, social, psycholo...
Multiple sclerosis (MS) is the most common neurological disease with disabling consequences that occ...
Objective: People with multiple sclerosis often suffer from distress, reduced societal participation...
Adherence to disease-modifying treatments is essential in order to maximize the beneficial effects o...
Fahad D Alosaimi,1 Alaa AlMulhem,2 Hanan AlShalan,2 Mohammad Alqazlan,3 Abdulgader Aldaif,4 Matthew ...
Objective: People with multiple sclerosis often suffer from distress, reduced societal participation...
AbstractMultiple sclerosis (MS) is an unpredictable, inflammatory, chronic, potentially disabling, n...
Objective Multiple Sclerosis (MS) as a progressive disease has remarkable consequences on the patien...
Objective: This cross-sectional study aims to evaluate the impact of the disability status, psycholo...
WOS: 000444552800005PubMed ID: 30138155Background: Adherence to medication treatment in patients wit...
BACKGROUND: Health-related quality of life (QOL) is a key outcome for people with multiple sclerosis...
Purpose. Quality of life (QoL) is an important measure of the burden of disease and could be useful ...
Objective: The aim of this study was to obtain information concerning the relationship between the s...
Optimizing quality of life (QOL) and self-management in people with multiple sclerosis (MS) is incre...
Multiple sclerosis (MS) is one of the most disabling chronic neurological diseases. Individual perce...
Background and Objectives Multiple sclerosis (MS) has a broad spectrum of physical, social, psycholo...
Multiple sclerosis (MS) is the most common neurological disease with disabling consequences that occ...
Objective: People with multiple sclerosis often suffer from distress, reduced societal participation...
Adherence to disease-modifying treatments is essential in order to maximize the beneficial effects o...
Fahad D Alosaimi,1 Alaa AlMulhem,2 Hanan AlShalan,2 Mohammad Alqazlan,3 Abdulgader Aldaif,4 Matthew ...
Objective: People with multiple sclerosis often suffer from distress, reduced societal participation...
AbstractMultiple sclerosis (MS) is an unpredictable, inflammatory, chronic, potentially disabling, n...
Objective Multiple Sclerosis (MS) as a progressive disease has remarkable consequences on the patien...